We are live on ! Find out more
PHGE icon

BiomX
PHGE

18 hedge funds and large institutions have $4.41M invested in BiomX in 2025 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 18 → 18 (0)

0% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 4

0.53% less ownership

Funds ownership: 2.2% → 1.67% (-0.53%)

10% less capital invested

Capital invested by funds: $4.92M → $4.41M (-$507K)

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

Holders
18
Holders Change
–
Holders Change %
0%
% of All Funds
0.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
1
Reduced
3
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$772K
2
Citadel Advisors
Citadel Advisors
Florida
+$78.6K
3
Renaissance Technologies
Renaissance Technologies
New York
+$37.4K
4
Two Sigma Investments
Two Sigma Investments
New York
+$9.29K
5
UBS Group
UBS Group
Switzerland
+$1.19K

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$834K
2
ACM
AIGH Capital Management
Maryland
-$705K
3
IC
Ikarian Capital
Texas
-$243K
4
ACM
ADAR1 Capital Management
Texas
-$108K
5
BFM
Boothbay Fund Management
New York
-$64.5K
Name Holding Trade Value Shares
Change 		Change in
Stake
DM
1
Deerfield Management
New York
$1.31M – – –
NCM
2
Nantahala Capital Management
Connecticut
$1.31M – – –
Alyeska Investment Group
3
Alyeska Investment Group
Illinois
$835K +$772K +83,723 New
JP Morgan Chase
4
JP Morgan Chase
New York
$226K – – –
DCM
5
DAFNA Capital Management
California
$211K – – –
IC
6
Ikarian Capital
Texas
$206K -$243K -26,316 -56%
Citadel Advisors
7
Citadel Advisors
Florida
$84.9K +$78.6K +8,515 New
BFM
8
Boothbay Fund Management
New York
$54.8K -$64.5K -6,995 -56%
Renaissance Technologies
9
Renaissance Technologies
New York
$53.8K +$37.4K +4,059 +305%
JJ
10
Johnson & Johnson
New Jersey
$50.9K – – –
ACM
11
ADAR1 Capital Management
Texas
$40.8K -$108K -11,681 -74%
Barclays
12
Barclays
United Kingdom
$13.1K – – –
Two Sigma Investments
13
Two Sigma Investments
New York
$10K +$9.29K +1,007 New
TSS
14
Two Sigma Securities
New York
$5.55K – – –
UBS Group
15
UBS Group
Switzerland
$1.28K +$1.19K +129 New
CS
16
Clear Street
New York
$1.19K – – –
SS
17
SBI Securities
Japan
$210 – – –
CWA
18
Carolina Wealth Advisors
South Carolina
$83 – – –
Bank of America
19
Bank of America
North Carolina
$1 – – –
Morgan Stanley
20
Morgan Stanley
New York
– -$834K -97,581 Closed
ACM
21
AIGH Capital Management
Maryland
– -$705K -82,471 Closed
WAM
22
Warberg Asset Management
Illinois
– -$36K -4,211 Closed
XT
23
XTX Topco
Cayman Islands
– -$11.2K -1,310 Closed

PHGE Hedge Fund Activity: Q3 2025 in Review

18 of the 7,629 institutional investors tracked by Wall St. Rank reported a position in BiomX (PHGE) for Q3 2025, worth a combined $4.41M — down 10% from $4.92M a quarter earlier.

Fund positioning in PHGE was balanced in Q3 2025: 4 funds opened new positions, 4 closed out, 1 added to existing stakes and 3 trimmed.

The largest buyer was Alyeska Investment Group, opening a new position worth an estimated $772K. The largest seller was Morgan Stanley, exiting entirely with an estimated $834K sold.

  • 18 institutional investors held BiomX (PHGE) as of Q3 2025, unchanged from Q2 2025.
  • Funds reported $4.41M of BiomX stock for Q3 2025, down 10% quarter-over-quarter.
  • 4 funds opened new BiomX positions in Q3 2025 and 4 closed out, a net change of 0 holders.
  • The largest BiomX buyer in Q3 2025 was Alyeska Investment Group, an estimated $772K added.
  • The largest BiomX seller in Q3 2025 was Morgan Stanley, an estimated $834K sold.

Based on aggregated 13F filings for Q3 2025.